Black Hawk Acquisition Corp and Vesicor Therapeutics Enter Forward Purchase Agreement with Meteora for Up to 1.35M Shares; Company To Domesticate As A Delaware Corporation And Change Name To Vesicor Therapeutics Holdings; Co To Pay Meteora Final Redemption Price Less $0.75 Per Backstop Investor Share; Vesicor Therapeutics Holdings May Sell Up To $200M Of Common Stock To Meteora Over 36 Months
On September 22, 2026, Black Hawk Acquisition Corporation, a Cayman Islands exempted company ("BKHA" or the "Company"), and Vesicor Therapeutics, Inc., a California corporation ("Vesicor"),
A company called Black Hawk is joining with Vesicor Therapeutics and making big changes. They are moving to Delaware, getting a new name, and raising money by selling stock over the next three years.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.